Packaging shown of the product. In those with non-valvular atrial fibrillation, it appears to be as effective as warfarin in preventing ischemic strokes and embolic events.<unk>  is associated with lower rates of serious and fatal bleeding events than warfarin, though<unk>  is associated with higher rates of bleeding in the gastrointestinal tract. In July 2012, the UK's National Institute for Health and Clinical Excellence recommended<unk>  to prevent and treat venous thromboembolism.
Rivaroxaban
Apixaban
Dabigatran
Ticlopidine
Enoxaparin sodium
Ticagrelor
Eptifibatide
Palladin